PEBank: A database for protein engineering data
PEBank:蛋白质工程数据数据库
基本信息
- 批准号:9377328
- 负责人:
- 金额:$ 59.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:Amino Acid SequenceBase SequenceBiological AssayCommunitiesCompanionsCorrelation StudiesDataData AnalysesData ElementData EngineeringData SetDatabasesDepositionDevelopmentDiagnosticDiseaseEnzymesFeedbackGenbankGoalsHealthHealthcareHumanHybridsIndividualMetabolic DiseasesMethodsModificationOnline SystemsPharmaceutical PreparationsPhasePoliciesProtein DatabasesProtein EngineeringProteinsProtocols documentationPublished CommentResearchScientistSecureSoftware DesignStructureTestingTherapeutic antibodiesTimeWritingcancer therapycloud basedcohesiondata integritydata sharingdesignimprovedorganizational structureprocess optimizationprotein structureprototypepublic health relevancesmall moleculetherapeutic proteintoolweb servicesweb-enabled
项目摘要
DESCRIPTION (provided by applicant): Engineered proteins such as therapeutic antibodies, specialized enzymes for drug manufacturing, and proteins used to identify new small molecule drugs are making significant contributions to improve health care. Protein therapeutics alone represent a $100+ billion market that is rapidly growing and has broad applications in the treatment of cancer, metabolic diseases, and other disorders. These advances have been made possible, in part, by the free and easy access to data in the form of nucleotide sequences (GenBank) and protein structures (Protein Data Bank, PDB). Both of these databases have grown exponentially and continue to organize and structure data in a manner that would be hard for individual groups or companies to maintain on their own. A new type of data is emerging in the protein engineering community that is not stored in GenBank or the PDB-engineered protein sequences and their associated experimental assay data. The protein engineering community is at a relatively early stage of development compared to the sequence or structure determination communities. Thus, the time is ripe to develop a database to organize the data from protein engineering studies into a cohesive and comprehensive dataset. We will call this database PEBank. In Phase I, PEBank development will include: (1) drafting a specification for Version 1.0, with feedback from representatives from GenBank and the PDB, that describes the types of data to be stored and lays out the organizational hierarchy of the data; (2) implementing a prototype of Version 1.0 of PEBank and garnering feedback from the protein engineering community; (3) implementing a cloud-based version of PEBank; and (4) creating web-based utilities for depositing, viewing, and analyzing data. In Phase II, we will continue development of
PEBank by: (1) creating a version that will allow write privileges and hosting it on Amazon Web Services; (2) providing support for PEBank users; (3) developing a secure limited-access version of PEBank that will hold customer-specific proprietary data; (4) developing tools that will
validate the intregrity of the data and policies to handle invalid data; (5) developing web-enabled
search tools to extract data from PEBank; (6) testing data deposit and viewing, and making PEBank available to the academic community; and (7) developing advanced analysis tools for finding statistical correlations between various data elements. We will also begin to use the analysis tools and PEBank data to optimize the predictive capability of our computational protein design software; this will include improving the underlying score functions and developing dynamic design tools that integrate database interrogation with the sequence optimization process. When complete, PEBank will allow protein engineers around the world to access protein engineering data in a standard format that can be easily accessed, searched, and shared; this data can be used to inform their designs and to develop more predictive protein design tools, thus accelerating the development of new and improved proteins for therapeutic, diagnostic, and other health-related applications.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barry D Olafson其他文献
Barry D Olafson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barry D Olafson', 18)}}的其他基金
PEBank: A database for protein engineering data
PEBank:蛋白质工程数据数据库
- 批准号:
9141872 - 财政年份:2016
- 资助金额:
$ 59.13万 - 项目类别:
TriadWeb: An easy-to-use web-based platform for protein engineering.
TriadWeb:一个易于使用的基于网络的蛋白质工程平台。
- 批准号:
8834160 - 财政年份:2014
- 资助金额:
$ 59.13万 - 项目类别:
相似海外基金
Quantum chemical challenge to elucidate the functional mechanism of base sequence specificity deciding removal of the DNA damage
量子化学挑战阐明碱基序列特异性决定去除 DNA 损伤的功能机制
- 批准号:
19K22903 - 财政年份:2019
- 资助金额:
$ 59.13万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Theoretical Study on Relation of Base sequence and Electronic Structures toward Elucidation of Mechanism of DNA Electric Conductivity.
碱基序列与电子结构关系的理论研究,阐明DNA导电机制。
- 批准号:
16K05666 - 财政年份:2016
- 资助金额:
$ 59.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prediction and control of base sequence recognition ability for nucleic acid binding proteins by using computer experiments.
利用计算机实验预测和控制核酸结合蛋白的碱基序列识别能力。
- 批准号:
14598001 - 财政年份:2002
- 资助金额:
$ 59.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
FLANKING BASE SEQUENCE ON MUTAGENICITY OF 8 OXOGUANINE
8 氧鸟嘌呤致突变性的侧翼碱基序列
- 批准号:
6362773 - 财政年份:2001
- 资助金额:
$ 59.13万 - 项目类别:
FLANKING BASE SEQUENCE ON MUTAGENICITY OF 8 OXOGUANINE
8 氧鸟嘌呤致突变性的侧翼碱基序列
- 批准号:
6137753 - 财政年份:2000
- 资助金额:
$ 59.13万 - 项目类别:
GROWTH HOROMON LOCALIZATION AND ITS BASE SEQUENCE IN BOVINE PANCREATIC
牛胰腺生长激素定位及其碱基序列
- 批准号:
10460134 - 财政年份:1998
- 资助金额:
$ 59.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
2488608 - 财政年份:1997
- 资助金额:
$ 59.13万 - 项目类别:
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
6475917 - 财政年份:1997
- 资助金额:
$ 59.13万 - 项目类别:
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
6329024 - 财政年份:1997
- 资助金额:
$ 59.13万 - 项目类别:
DNA BASE SEQUENCE EFFECTS IN CHEMICAL CARCINOGENESIS
DNA 碱基序列在化学致癌作用中的作用
- 批准号:
6124462 - 财政年份:1997
- 资助金额:
$ 59.13万 - 项目类别: